2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole
C51H30N2O2S — CID 164783951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole
2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole (PubChem CID 164783951) has the molecular formula C51H30N2O2S and a molecular weight of 734.88 g/mol. Its IUPAC name is 2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole |
|---|---|
| PubChem CID | 164783951 |
| Molecular Formula | C51H30N2O2S |
| Molecular Weight | 734.88 g/mol |
| Exact Mass | 734.20 |
| IUPAC Name | 2-[3-(1,3-benzothiazol-2-yl)-5-(3-spiro[fluorene-9,9'-xanthene]-2-ylphenyl)phenyl]-1,3-benzoxazole |
| SMILES | c1cc(-c2cc(-c3nc4ccccc4o3)cc(-c3nc4ccccc4s3)c2)cc(-c2ccc3c(c2)C2(c4ccccc4Oc4ccccc42)c2ccccc2-3)c1 |
| InChI | InChI=1S/C51H30N2O2S/c1-2-15-39-37(14-1)38-25-24-33(30-42(38)51(39)40-16-3-7-20-45(40)54-46-21-8-4-17-41(46)51)31-12-11-13-32(26-31)34-27-35(49-52-43-18-5-9-22-47(43)55-49)29-36(28-34)50-53-44-19-6-10-23-48(44)56-50/h1-30H |
| InChIKey | GAEFTDJMDGGYIF-UHFFFAOYSA-N |
| XLogP | 13.57 |
| TPSA | 48.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 56 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 734.88 |
| LogP ≤ 5 | 13.57 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164783951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.